protein

PDE3A Protein, Human (sf9, His-GST)

HY-P75961

5 μg;10 μg;50 μg

112;190;528 USD

PDE3A Protein, Human (sf9, His-GST)

proteins

Sf9 insect cells

5 μg;10 μg;50 μg

112;190;528 USD

PDE3A protein, a cyclic nucleotide phosphodiesterase, targets cAMP, cGMP, and cUMP, crucial in diverse physiological processes. In an E2/17beta-estradiol-induced pro-apoptotic pathway, E2 stabilizes the PDE3A/SLFN12 complex, leading to SLFN12 dephosphorylation and activating its pro-apoptotic ribonuclease activity. This pathway is implicated in tissues with high E2 concentrations, potentially contributing to processes like placenta remodeling. PDE3A Protein, Human (sf9, His-GST) is the recombinant human-derived PDE3A protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag. The total length of PDE3A Protein, Human (sf9, His-GST) is 473 a.a., with molecular weight of ~93 kDa.

Human

PDE3A protein, a cyclic nucleotide phosphodiesterase, exhibits specificity for the second messengers cAMP and cGMP, crucial regulators in diverse physiological processes. Additionally, PDE3A demonstrates activity toward cUMP. Beyond its catalytic role, PDE3A is a component of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. Estradiol (E2) stabilizes the PDE3A/SLFN12 complex in the cytosol, leading to the dephosphorylation of SLFN12 and activation of its pro-apoptotic ribonuclease activity. This apoptotic pathway is implicated in tissues with high concentrations of E2 and may play a role in processes such as placenta remodeling.

cGMP-inhibited 3',5'-cyclic phosphodiesterase A; CGI-PDE A; PDE3A

Greater than 90% as determined by reducing SDS-PAGE

Supplied as a 0.2 μm filtered solution of 20 mM Tris, 500 mM NaCl, pH 7.4, 10% gly, 3 mM DTT.

Shipping with dry ice.